KS
Kedar Shriram Bobade
About Kedar Shriram Bobade
Kedar Shriram Bobade has 7 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Ascenify Consultancy Private Limited. Formerly with 3 companies, such as Spy Graphics Private Limited and Norworth Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ascenify Consultancy Private Limited
U74994DL2019PTC357159
|
Additional Director | 19 Sep 2023 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Spy Graphics Private Limited
U46900DL2013PTC257887
|
Additional Director | 02 May 2023 | 2013 | Active |
Norworth Pharmaceuticals Private Limited
U24294CT2018PTC008869
|
Director | 01 Aug 2022 | 2018 | Active |
Nexonn Business Private Limited
U74999DL2019PTC345009
|
Director | 25 Jan 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kedar Shriram Bobade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kedar Shriram Bobade
Kedar Shriram Bobade has 7 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Ascenify Consultancy Private Limited. Formerly with 3 companies, such as Spy Graphics Private Limited and Norworth Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Kedar Shriram Bobade is associated with 1 company as Additional Director.
Kedar Shriram Bobade has expertise in General Business.
Kedar Shriram Bobade has 7 years in corporate governance.